Squamous and basal cell carcinoma in heart transplant recipients

T. D. Lampros, A. Cobanoglu, F. Parker, R. Ratkovec, D. J. Norman, R. Hershberger

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


Background: Cutaneous malignancies are frequent in organ transplant recipients. We retrospectively reviewed a large series of heart transplant recipients and report on the prevalence and risk factors for development of cutaneous squamous and basal cell carcinoma. Methods: Between Dec. 4, 1985, and Dec. 27, 1996, 299 heart transplantations were performed at the Oregon Health Sciences University. Heart transplant recipients with more than 6 months survival or follow-up were investigated for squamous and basal cell carcinoma (n = 248). Results: Forty-one patients (17%) were found to have 192 squamous or basal cell carcinomas. Squamous cell carcinoma was the predominate skin malignancy, constituting 172 (90%) of the lesions. The mean number of skin malignancies per patient was 4.7 ± 0.81 (range 125). Patients with development of a skin malignancy were 8 years older on average, with a male-to female ratio of 19.5:1. The predominant skin type and eye color were fair (59%) and blue (59%), respectively. Cumulative risk, based on actuarial survival analysis for development of a squamous or basal cell carcinoma at 1 year, was 3% and increased to 21% and 35% at 5 and 10 years, respectively. In addition, cumulative risk increased in patients who received treatment with OKT3. Conclusion: Cumulative risk of development of a skin malignancy increased with time and use of OKT3. Additional patient risk factors included older age, male sex, fair skin, and blue eyes.

Original languageEnglish (US)
Pages (from-to)586-591
Number of pages6
JournalJournal of Heart and Lung Transplantation
Issue number6
StatePublished - 1998

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation


Dive into the research topics of 'Squamous and basal cell carcinoma in heart transplant recipients'. Together they form a unique fingerprint.

Cite this